Evidence map›Paper›PMID 33375207›Full record

ReviewInternational journal of molecular sciences2020

Role of NMR in High Ordered Structure Characterization of Monoclonal Antibodies.

Yuji Tokunaga, Koh Takeuchi

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Peptide Antibodies: Current Status.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  7. Article
  8. Review
  9. Expression ofEPJ web of conferences · 2023
    Article
  10. Review
  11. Inhaled antibodies: Quality and performance considerations.Human vaccines & immunotherapeutics · 2022
    Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Yuji TokunagaMolecular Profiling Research Center for Drug Discovery, National Institute of Advanced Industrial Science and Technology, Tokyo 135-0064, Japan.
Koh TakeuchiMolecular Profiling Research Center for Drug Discovery, National Institute of Advanced Industrial Science and Technology, Tokyo 135-0064, Japan.ORCID 0000-0002-6227-4627

Funding

Japan Society for the Promotion of Science JP18K19415Japan Society for the Promotion of Science JP20H03378Japan Society for the Promotion of Science JP20H04722Takeda Science Foundation NA
6 · The paper itself

Abstract

Obtaining high ordered structure (HOS) information is of importance to guarantee the efficacy and safety of monoclonal antibodies (mAbs) in clinical application. Assessment of HOS should ideally be performed in a non-invasive manner under their formulated storage conditions, as any perturbation can introduce unexpected detritions. However, most of the currently available techniques only indirectly report HOS of mAbs and/or require a certain condition to conduct the analyses. Besides, the flexible multidomain architecture of mAbs has hampered atomic-resolution structural analyses using X-ray crystallography and cryo-electron microscopy. In contrast, the ability of nuclear magnetic resonance (NMR) spectroscopy to structurally analyze biomolecules in various conditions in a non-invasive and quantitative manner is suitable to meet the needs. However, the application of NMR to mAbs is not straightforward due to the high molecular weight of the system. In this review, we will discuss how NMR techniques have been applied to HOS analysis of mAbs, along with the recent advances of the novel

Indexed as

Models, MolecularProtein ConformationAntibodies, MonoclonalCryoelectron MicroscopyCrystallography, X-RayGlycosylationImmunoglobulin Fc FragmentsImmunoglobulin GMagnetic Resonance SpectroscopyProtein StabilityAntibodies, MonoclonalImmunoglobulin Fc FragmentsImmunoglobulin G15N-direct detectionformulation conditionhigh ordered structuremonoclonal antibodiesmulti domainNMR

Identifiers

PMID33375207
PMCPMC7793058

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.